Research & Literature

Immunotactoid Glomerulopathy and Cryoglobulinemic Nephropathy: Two Entities with Many Similarities. A Unified Conceptual Approach.

Herrera GA, Ojemakinde KO, Turbat-Herrera EA, et al.

Ultrastructural pathology 2015; (39(4)):270-80 doi:10.3109/01913123.2015.1017070.

End-Stage Kidney Disease Due to Fibrillary Glomerulonephritis and Immunotactoid Glomerulopathy - Outcomes in 66 Consecutive ANZDATA Registry Cases.

Mallett A, Tang W, Hart G, et al.

American journal of nephrology 2015; (42(3)):177-84 doi:10.1159/000440815.

[Glomerulopathies with organized monoclonal immunoglobulin deposits].

Touchard G, Bridoux F, Goujon JM

Nephrologie & therapeutique 2016; (12(1)):57-65.

A case report of unusually long lag time between immunotactoid glomerulopathy (itg) diagnosis and diffuse large B-cell lymphoma (DLBCL) development.

Khandelwal A, Trinkaus MA, Ghaffar H, et al.

BMC nephrology 2016; (17(1)):140 doi:10.1186/s12882-016-0349-9.

[Pathology and differential diagnosis of immunotactoid glomerulopathy].

Sun XL, Zhang FC, Xiao Y, et al.

Zhonghua bing li xue za zhi = Chinese journal of pathology 2016; (45(10)):703-706 doi:10.3760/cma.j.issn.0529-5807.2016.10.007.

Diagnosis and management of nephrotic syndrome.

McCloskey O, Maxwell AP

The Practitioner 2017; (261(1801)):11-5.

Dysproteinemias and Glomerular Disease.

Leung N, Drosou ME, Nasr SH

Clinical journal of the American Society of Nephrology : CJASN 2018; (13(1)):128-139 doi:10.2215/CJN.00560117.

DNAJB9 Is a Specific Immunohistochemical Marker for Fibrillary Glomerulonephritis.

Nasr SH, Vrana JA, Dasari S, et al.

Kidney international reports 2018; (3(1)):56-64 doi:10.1016/j.ekir.2017.07.017.

A case report of POEMS syndrome with renal involvement as immunotactoid glomerulopathy.

Wang Y, Yan Y, Sui Z, et al.

Medicine 2018; (97(9)):e9920 doi:10.1097/MD.0000000000009920.

A case of immunotactoid glomerulopathy with false-negative IgG staining.

Hirashio S, Arima T, Satoh A, et al.

BMC nephrology 2018; (19(1)):143 doi:10.1186/s12882-018-0931-4.

The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research Group.

Leung N, Bridoux F, Batuman V, et al.

Nature reviews. Nephrology 2019; (15(1)):45-59 doi:10.1038/s41581-018-0077-4.

HCV-Associated Nephropathies in the Era of Direct Acting Antiviral Agents.

Angeletti A, Cantarelli C, Cravedi P

Frontiers in medicine 2019; (6()):20 doi:10.3389/fmed.2019.00020.

Results of a nation-wide cohort study suggest favorable long-term outcomes of clone-targeted chemotherapy in immunotactoid glomerulopathy.

Javaugue V, Dufour-Nourigat L, Desport E, et al.

Kidney international 2021; (99(2)):421-430 doi:10.1016/j.kint.2020.06.039.

Immunotactoid glomerulopathy is a rare entity with monoclonal and polyclonal variants.

Nasr SH, Kudose SS, Said SM, et al.

Kidney international 2021; (99(2)):410-420 doi:10.1016/j.kint.2020.07.037.

Monoclonal Gammopathy of Renal Significance: Clinical and Histological Efficacy of a Bortezomib-Based Regimen.

Quattrocchio G, Barreca A, Vaccarino A, et al.

Frontiers in medicine 2020; (7()):587345 doi:10.3389/fmed.2020.587345.

Immunotactoid glomerulonephritis in a patient with cold agglutinins: causal association or mere coincidence?

Morimoto N, Nagahama K, Oyama S, et al.

CEN case reports 2021; (10(4)):515-522 doi:10.1007/s13730-021-00600-2.

Immunotactoid Glomerulopathy with Nontuberculous Mycobacterial Infection: A Novel Association.

Shimizu Y, Wakabayashi K, Iwasaki H, et al.

Case reports in nephrology and dialysis 2021; (11(2)):136-146 doi:10.1159/000515583.

Monoclonal gammopathy of renal significance: Spectrum of diseases and approach to a case.

Tewari R, Chatterjee T, Mendonca S, et al.

Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia 2021; (32(2)):298-306 doi:10.4103/1319-2442.335440.

Immunotactoid glomerulopathy - an enigmatic case in the setting of nodal marginal zone lymphoma and systemic sclerosis sine scleroderma.

Mohamed MW, Al-Hammadi M, Hussein AM, et al.

BMC nephrology 2022; (23(1)):103 doi:10.1186/s12882-022-02730-w.

Diagnosis of monoclonal immunotactoid glomerulopathy with positive λ chain by immunoelectron microscopy.

Sugita E, Sonoda H, Ryuzaki M, et al.

CEN case reports 2023; (12(1)):7-13 doi:10.1007/s13730-022-00714-1.

Light Chain-Only Immunotactoid Glomerulopathy: A Case Report.

Bu L, Javaugue V, Chauvet S, et al.

American journal of kidney diseases : the official journal of the National Kidney Foundation 2023; (81(5)):611-615 doi:10.1053/j.ajkd.2022.08.025.

Monoclonal gammopathy of renal significance: Multidisciplinary approach to diagnosis and treatment.

Karam S, Haidous M, Dalle IA, et al.

Critical reviews in oncology/hematology 2023; (183()):103926 doi:10.1016/j.critrevonc.2023.103926.

A Rare Case of Recurrent Immunotactoid Glomerulonephritis.

Doraiswamy M, Parikh SV, Brodsky S

Cureus 2023; (15(2)):e35136 doi:10.7759/cureus.35136.

Immunotactoid Glomerulopathy: A Rare Glomerular Disease Case Study.

Karanfilovski V, Ristovska V, Gjorgjievski N, et al.

Indian journal of nephrology 2023; (33(2)):140-143 doi:10.4103/ijn.ijn_107_22.

Glomerulopathies with Fibrillary Deposits.

Dzekova-Vidimliski P, Karanfilovski V, Nikolov IG, et al.

Prilozi (Makedonska akademija na naukite i umetnostite. Oddelenie za medicinski nauki) 2023; (44(2)):99-106 doi:10.2478/prilozi-2023-0030.

Immunotactoid Glomerulopathy.

Abramson M, Shaikh A

Advances in kidney disease and health 2024; (31(4)):326-333 doi:10.1053/j.akdh.2024.03.003.

Immunotactoid Glomerulopathy Masquerading as Heart Failure.

Ali K, Agrawal A, Karan A, et al.

Cureus 2024; (16(7)):e63687 doi:10.7759/cureus.63687.

Successful Treatment of Monoclonal Immunotactoid Glomerulopathy Associated with Chronic Lymphocytic Leukemia Using Ibrutinib.

Saito A, Kameoka Y, Ubukawa K, et al.

Internal medicine (Tokyo, Japan) 2025; (64(9)):1388-1392 doi:10.2169/internalmedicine.3902-24.

Renal manifestations of MGUS.

Bridoux F, Nasr SH, Arnulf B, et al.

Hematology. American Society of Hematology. Education Program 2024; (2024(1)):489-498 doi:10.1182/hematology.2024000573.

Diagnosis and management of monoclonal gammopathy of renal significance: A British Society for Haematology good practice paper.

Pinney J, Roufosse C, Kousios A, et al.

British journal of haematology 2025; (206(2)):447-463 doi:10.1111/bjh.19956.

Monoclonal gammopathy of renal significance (MGRS): retrospective monocentric analysis of clinical outcomes and treatment strategies.

Esposito P, Macciò L, Cagnetta A, et al.

Clinical and experimental medicine 2025; (25(1)):118 doi:10.1007/s10238-025-01646-7.

Heavy Chain Deposition Disease in Monoclonal Gammopathy of Renal Significance: A Prodrome of Multiple Myeloma Case and Literature Review.

Gnanasampanthan S, Samelis VP, Roufosse C, Kousios A

Cureus 2025; (17(6)):e85740 doi:10.7759/cureus.85740.

Recurrent immunotactoid glomerulopathy in a kidney transplant recipient: Case report.

Yu S, Zhao X, Cheng F, et al.

Medicine 2025; (104(31)):e43673 doi:10.1097/MD.0000000000043673.

Treatment with Daratumumab for Immunotactoid Glomerulopathy Associated with Plasma Cell Dyscrasia: A Report of Two Cases.

Uehara A, Oura M, Ikeda D, et al.

Internal medicine (Tokyo, Japan) 2026; (65(9)):1268-1272 doi:10.2169/internalmedicine.5165-24.

Immunotactoid Glomerulopathy in a Patient With HIV and Anti-hepatitis C Virus (HCV) Positivity: A Unique Clinical Entity.

Wagle A, Shrestha R, Varma N

Cureus 2025; (17(8)):e90015 doi:10.7759/cureus.90015.

Immunotactoid glomerulopathy in rheumatoid arthritis.

Dejman A, Velez Torres JM, Tjendra Y, et al.

Clinical nephrology. Case studies 2025; (13()):77-83 doi:10.5414/CNCS111805.

Sequential Treatment With Corticosteroids and Cyclosporine A in a High-Risk Patient With IgG-Negative Immunotactoid Glomerulopathy.

Inoue M, Asai C, Kamegai N, Yamamoto J

Cureus 2026; (18(2)):e104280 doi:10.7759/cureus.104280.

Executive summary of the European consensus report on the diagnosis and treatment of monoclonal gammopathy of renal significance.

Sprangers B, Cohen C, Gnemmi V, et al.

Clinical kidney journal 2026; (19(6)):sfag163 doi:10.1093/ckj/sfag163.

Efficacy and safety of reduced-dose daratumumab plus bortezomib and dexamethasone (DVd-lite) in newly diagnosed MGRS patients.

Xie H, Xiang M, Zhang M, et al.

Frontiers in immunology 2026; (17()):1722204 doi:10.3389/fimmu.2026.1722204.